While mid-life obesity and systemic metabolic changes, such as high leptin circulating levels, are risk factors in the development of dementia, low plasma leptin levels later in life are associated with worsening cognitive decline and increased risk of developing AD [62,63]. This evidence concerns the gene LEP and Alzheimer disease.